Yong-Ping Chen (Yongping Chen)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Low Density Lipoprotein

Cerebrospinal Fluid

Amyotrophic Lateral Sclerosis

Gene Expression

Top Venues

Journal of cachexia, sarcopenia and muscle

Molecular neurobiology

Journal of neurology, neurosurgery, and psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Kang-Fu Yin, Ting Chen, Xiao-Jing Gu, Wei-Ming Su, Zheng Jiang, Si-Jia Lu, Bei Cao, Li-Yi Chi, Xia Gao, Yong-Ping Chen
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia. Journal of cachexia, sarcopenia and muscle 15 (4) (2024)
Kang-Fu Yin, Ting Chen, Xiao-Jing Gu, Wei-Ming Su, Zheng Jiang, Si-Jia Lu, Bei Cao, Li-Yi Chi, Xia Gao, Yong-Ping Chen
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia. Journal of cachexia, sarcopenia and muscle 15 (4) (2024)
Zheng Jiang, Xiao-Jing Gu, Wei-Ming Su, Qing-Qing Duan, Kang-Fu Yin, Yan-Lin Ren, Yi Wang, Bei Cao, Yong-Ping Chen
Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian Randomization. Molecular neurobiology 61 (9) (2024)
Kang-Fu Yin, Ting Chen, Xiao-Jing Gu, Wei-Ming Su, Zheng Jiang, Si-Jia Lu, Bei Cao, Li-Yi Chi, Xia Gao, Yong-Ping Chen
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia. Journal of cachexia, sarcopenia and muscle 15 (4) (2024)
Zheng Jiang, Xiao-Jing Gu, Wei-Ming Su, Qing-Qing Duan, Kang-Fu Yin, Yan-Lin Ren, Yi Wang, Bei Cao, Yong-Ping Chen
Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian Randomization. Molecular neurobiology 61 (9) (2024)
Qing-Qing Duan, Han Wang, Wei-Ming Su, Xiao-Jing Gu, Xiao-Fei Shen, Zheng Jiang, Yan-Ling Ren, Bei Cao, Guo-Bo Li, Yi Wang, Yong-Ping Chen
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro. BMC medicine 22 (1) (2024)
Zheng Jiang, Xiao-Jing Gu, Wei-Ming Su, Qing-Qing Duan, Kang-Fu Yin, Yan-Lin Ren, Yi Wang, Bei Cao, Yong-Ping Chen
Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian Randomization. Molecular neurobiology (2024)
Qing-Qing Duan, Han Wang, Wei-Ming Su, Xiao-Jing Gu, Xiao-Fei Shen, Zheng Jiang, Yan-Ling Ren, Bei Cao, Guo-Bo Li, Yi Wang, Yong-Ping Chen
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro. BMC medicine 22 (1) (2024)
Kang-Fu Yin, Ting Chen, Xiao-Jing Gu, Wei-Ming Su, Zheng Jiang, Si-Jia Lu, Bei Cao, Li-Yi Chi, Xia Gao, Yong-Ping Chen
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia. Journal of cachexia, sarcopenia and muscle (2024)
Qing-Qing Duan, Han Wang, Wei-Ming Su, Xiao-Jing Gu, Xiao-Fei Shen, Zheng Jiang, Yan-Ling Ren, Bei Cao, Guo-Bo Li, Yi Wang, Yong-Ping Chen
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro. BMC medicine 22 (1) (2024)
Xiao-Jing Gu, Wei-Ming Su, Meng Dou, Zheng Jiang, Qing-Qing Duan, Kang-Fu Yin, Bei Cao, Yi Wang, Guo-Bo Li, Yong-Ping Chen
Expanding causal genes for Parkinson's disease via multi-omics analysis. NPJ Parkinson's disease 9 (1) (2023)
Wei-Ming Su, Xiao-Jing Gu, Meng Dou, Qing-Qing Duan, Zheng Jiang, Kang-Fu Yin, Wei-Chen Cai, Bei Cao, Yi Wang, Yong-Ping Chen
Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry (2023)
Xiao-Jing Gu, Wei-Ming Su, Meng Dou, Zheng Jiang, Qing-Qing Duan, Han Wang, Yan-Ling Ren, Bei Cao, Yi Wang, Yong-Ping Chen
Identifying novel genes for amyotrophic lateral sclerosis by integrating human brain proteomes with genome-wide association data. Journal of neurology (2023)
Xiaojing Gu, Meng Dou, Bei Cao, Zheng Jiang, Yong-Ping Chen
Peripheral level of CD33 and Alzheimer's disease: a bidirectional two-sample Mendelian randomization study. Translational psychiatry 12 (1) (2022)